OTTMUSG00000019268 Inhibitors
Inhibition of the protein Gm15143, as hypothesized in this context, involves a multifaceted approach targeting various biochemical and cellular pathways. Given the lack of direct inhibitors for Gm15143, the strategy revolves around modulating the cellular environment and signaling pathways to indirectly influence the activity and functional role of this protein. Rapamycin and LY294002 represent two distinct methods of indirect inhibition. Rapamycin targets the mTOR pathway, crucial for protein synthesis and cell proliferation. If Gm15143 is involved in these processes, its activity could be reduced by the diminished cellular growth and proliferation induced by mTOR inhibition. LY294002, on the other hand, inhibits the PI3K/Akt pathway, a key player in cell survival and metabolism. Inhibition of PI3K could lead to reduced activation of downstream targets, potentially including Gm15143 if it is a component of this pathway. Trichostatin A and SB431542 offer alternative mechanisms of action. Trichostatin A, by modifying chromatin structure, impacts gene expression regulation. If Gm15143 has a role in transcriptional regulation, its functional impact could be altered by these changes in gene expression patterns. SB431542 inhibits TGF-β signaling, influencing processes like cell differentiation. This might indirectly inhibit Gm15143 if it is implicated in the TGF-β pathway.
Kinase inhibitors like PD98059, Sorafenib, and Dasatinib present a common theme in targeting signaling pathways. PD98059's inhibition of the MEK in the MAPK/ERK pathway, Sorafenib's broad kinase inhibition impacting cell proliferation and survival pathways, and Dasatinib's targeting of Src-family kinases all represent potential methods to modulate the activity of Gm15143 if it is linked to these signaling cascades. Finally, proteasome and other kinase inhibitors like Bortezomib, SP600125, Wortmannin, U0126, and Gefitinib provide a spectrum of indirect inhibitory mechanisms. These range from altering protein degradation pathways, as in the case of Bortezomib, to modulating JNK, PI3K, MEK1/2, and EGFR pathways, each potentially impacting the functional role of Gm15143 if it is involved in these processes. In summary, the inhibition of Gm15143 through these chemicals is hypothesized based on their known actions on various cellular and signaling pathways. The effectiveness and specificity of this inhibition would require empirical validation, considering the indirect nature of these mechanisms and the current lack of direct inhibitors for Gm15143.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, can indirectly inhibit Gm15143 if the protein is involved in pathways related to cell growth and proliferation. By inhibiting mTOR, rapamycin reduces protein synthesis and cell proliferation, potentially reducing the functional activity of Gm15143 if it plays a role in these processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, could indirectly inhibit Gm15143 if this protein is associated with the PI3K/Akt pathway. By inhibiting PI3K, LY294002 reduces the downstream signaling that might be crucial for Gm15143's functional role, particularly in cell survival and metabolism. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, can indirectly inhibit Gm15143 if the protein is involved in gene expression regulation. By altering chromatin structure and gene expression, it might affect the functional role of Gm15143 in transcriptional regulation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542, a TGF-β receptor kinase inhibitor, could indirectly inhibit Gm15143 if the protein is part of the TGF-β signaling pathway. By blocking TGF-β signaling, SB431542 can modulate cellular processes like proliferation and differentiation where Gm15143 might be involved. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059, an MEK inhibitor, might indirectly inhibit Gm15143 if it is involved in the MAPK/ERK pathway. By inhibiting MEK, PD98059 reduces ERK pathway activity, potentially affecting Gm15143's role in cell division and growth. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, a proteasome inhibitor, could indirectly inhibit Gm15143 if the protein is involved in protein degradation pathways. By inhibiting the proteasome, bortezomib can affect the turnover of proteins, potentially impacting Gm15143's function if it is linked to proteostasis. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib, a kinase inhibitor, might indirectly inhibit Gm15143 if the protein is part of kinase-mediated signaling pathways. Sorafenib targets various kinases, potentially affecting pathways that Gm15143 is involved in, especially in cancer cell proliferation and survival. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
SP600125, a JNK inhibitor, could indirectly inhibit Gm15143 if it's involved in the stress-activated JNK pathway. By inhibiting JNK, SP600125 might impact the functional role of Gm15143 in stress response and apoptosis. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin, another PI3K inhibitor, can indirectly inhibit Gm15143 by targeting the PI3K pathway, similar to LY294002. This could affect Gm15143 if it's involved in PI3K-related signaling processes, impacting cell growth and survival. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126, an inhibitor of MEK1/2, can indirectly inhibit Gm15143 if the protein is associated with the MAPK/ERK pathway, similar to PD98059. By inhibiting MEK1/2, U0126 can affect Gm15143's potential role in cell signaling and proliferation. | ||||||